These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16940419)

  • 81. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.
    Wen J; Huang Y; Li H; Zhang X; Cheng P; Deng D; Peng Z; Luo J; Zhao W; Lai Y; Liu Z
    Int J Hematol; 2017 Jun; 105(6):777-783. PubMed ID: 28224273
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry.
    Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A
    Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Programmed necroptosis is upregulated in low-grade myelodysplastic syndromes and may play a role in the pathogenesis.
    Zou J; Shi Q; Chen H; Juskevicius R; Zinkel SS
    Exp Hematol; 2021 Nov; 103():60-72.e5. PubMed ID: 34563605
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome.
    Sokol L; Cripe L; Kantarjian H; Sekeres MA; Parmar S; Greenberg P; Goldberg SL; Bhushan V; Shammo J; Hohl R; Verma A; Garcia-Manero G; Li YP; Lowe A; Zhu J; List AF
    Leukemia; 2013 Apr; 27(4):977-80. PubMed ID: 23032694
    [No Abstract]   [Full Text] [Related]  

  • 85. p38 Mitogen-activated protein kinase and hematologic malignancies.
    Feng Y; Wen J; Chang CC
    Arch Pathol Lab Med; 2009 Nov; 133(11):1850-6. PubMed ID: 19886722
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Targeting inflammation in lower-risk MDS.
    Gonzalez-Lugo JD; Verma A
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):382-387. PubMed ID: 36485128
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Protein kinase R as mediator of the effects of interferon (IFN) gamma and tumor necrosis factor (TNF) alpha on normal and dysplastic hematopoiesis.
    Sharma B; Altman JK; Goussetis DJ; Verma AK; Platanias LC
    J Biol Chem; 2011 Aug; 286(31):27506-14. PubMed ID: 21659535
    [TBL] [Abstract][Full Text] [Related]  

  • 88. TLR7 ligation augments hematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signaling.
    Peña OA; Lubin A; Hockings C; Rowell J; Jung Y; Hoade Y; Dace P; Valdivia LE; Tuschl K; Böiers C; Virgilio MC; Richardson S; Payne EM
    Blood Adv; 2021 Oct; 5(20):4112-4124. PubMed ID: 34432872
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibition of LSD1 in MDS progenitors restores differentiation of CD141
    Srivastava P; Tzetzo SL; Gomez EC; Eng KH; Jani Sait SN; Kuechle JB; Singh PK; De Jong K; Wiatrowski KR; Peresie J; Dimitroff A; Lynch ML; Wang J; Abrams SI; Griffiths EA; Nemeth MJ
    Leukemia; 2020 Sep; 34(9):2460-2472. PubMed ID: 32099035
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Loss of Hspa9b in zebrafish recapitulates the ineffective hematopoiesis of the myelodysplastic syndrome.
    Craven SE; French D; Ye W; de Sauvage F; Rosenthal A
    Blood; 2005 May; 105(9):3528-34. PubMed ID: 15650063
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Why Single-Cell Sequencing Has Promise in MDS.
    Zhang X; Grimes HL
    Front Oncol; 2021; 11():769753. PubMed ID: 34926276
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The biology of myelodysplastic syndromes: unity despite heterogeneity.
    Raza A; Cruz R; Latif T; Mukherjee S; Galili N
    Hematol Rep; 2010 Jan; 2(1):e4. PubMed ID: 22184517
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Immune dysregulation in myelodysplastic syndrome.
    Sugimori C; List AF; Epling-Burnette PK
    Hematol Rep; 2010 Jan; 2(1):e1. PubMed ID: 22184512
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis.
    Head DR; Jacobberger JW; Mosse C; Jagasia M; Dupont W; Goodman S; Flye L; Shinar A; McClintock-Treep S; Stelzer G; Briggs R; Shults K
    Bone Marrow Res; 2011; 2011():950934. PubMed ID: 22046573
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw.
    Calvete O; Mestre J; Jerez A; Solé F
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900275
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Letter to Editor: Treatment with the apoptosis inhibitor asunercept reduces clone sizes in patients with lower risk myelodysplastic neoplasms.
    Zaidi SDEZ; Fatima Zaidi SM; Rangwala BS
    Ann Hematol; 2024 Jun; 103(6):2163-2164. PubMed ID: 38652243
    [No Abstract]   [Full Text] [Related]  

  • 97. Ex Vivo Expansion and Homing of Human Cord Blood Hematopoietic Stem Cells.
    Guo B; Huang X; Chen Y; Broxmeyer HE
    Adv Exp Med Biol; 2023; 1442():85-104. PubMed ID: 38228960
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Mesenchymal stem cells with p38 mitogen-activated protein kinase interference ameliorate mouse ischemic stroke.
    Bai Y; Wang L; Xu R; Cui Y
    Exp Biol Med (Maywood); 2023 Dec; 248(23):2481-2491. PubMed ID: 38158804
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Thermosensitive and antioxidant wound dressings capable of adaptively regulating TGFβ pathways promote diabetic wound healing.
    Niu H; Guan Y; Zhong T; Ma L; Zayed M; Guan J
    NPJ Regen Med; 2023 Jul; 8(1):32. PubMed ID: 37422462
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Heme oxygenase 1 in erythropoiesis: an important regulator beyond catalyzing heme catabolism.
    Liu R; Zhang X; Nie L; Sun S; Liu J; Chen H
    Ann Hematol; 2023 Jun; 102(6):1323-1332. PubMed ID: 37046065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.